CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
0.281
+0.032 (12.71%)
Nov 21, 2024, 11:54 AM EST - Market open
CERO Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 7.75 | 2.89 | 2.84 | 0.43 |
| Other Operating Expenses | 0.04 | 0.04 | 0.06 | 0.14 |
| Operating Expenses | 11.75 | 2.93 | 2.91 | 0.57 |
| Operating Income | -11.75 | -2.93 | -2.91 | -0.57 |
| Interest & Investment Income | 0.25 | 0.49 | 2.84 | - |
| EBT Excluding Unusual Items | -6.58 | -2.44 | -0.07 | -0.57 |
| Gain (Loss) on Sale of Investments | - | - | - | -0 |
| Pretax Income | -6.58 | -2.44 | -0.07 | -0.57 |
| Income Tax Expense | 0.07 | 0.09 | 0.6 | -0.03 |
| Net Income | -6.65 | -2.54 | -0.67 | -0.54 |
| Preferred Dividends & Other Adjustments | - | - | - | 36.16 |
| Net Income to Common | -6.65 | -2.54 | -0.67 | -36.71 |
| Shares Outstanding (Basic) | - | 7 | 22 | 10 |
| Shares Outstanding (Diluted) | - | 7 | 22 | 10 |
| Shares Change (YoY) | - | -70.97% | 133.12% | - |
| EPS (Basic) | - | -0.39 | -0.03 | - |
| EPS (Diluted) | - | -0.39 | -0.03 | - |
| Free Cash Flow | -9.13 | -1.52 | -1.09 | -1.2 |
| Free Cash Flow Per Share | - | -0.23 | -0.05 | -0.12 |
| EBIT | -11.75 | -2.93 | -2.91 | -0.57 |
Source: S&P Capital IQ. Standard template.
Financial Sources.